Regulatory Affairs Certification (RAC) Practice Exam Flash Cards

Disable ads (and more) with a membership for a one time $2.99 payment

Question: 1 / 50

What information related to a clinical investigator who conducts Phase I pharmacokinetic studies must be disclosed with your IND submission if they receive a retainer for another product?

?

No additional forms are required

Next

Report this question